ClinicalTrials.gov
ClinicalTrials.gov Menu

Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01709487
Recruitment Status : Completed
First Posted : October 18, 2012
Last Update Posted : February 24, 2016
Sponsor:
Information provided by (Responsible Party):
Jules Bordet Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2015
  Actual Study Completion Date : October 2015